ISSN (Print):
ISSN (Online):
Download PDF Flyer

Current Neuropharmacology

Impact Factor: 5.3

Indexed in: Scopus, SCI Expanded, MEDLINE/PubMed... View all

Volume 22 , Issues 14, 2024

Institutional Members

Editorial Board

cn Editor-in-Chief cn_ebm_nicoletti_001 Nicoletti Ferdinando Department of Pharmaceutical Sciences University Rome"da Sapienza" Rome Italy

Dr. Ferdinando Nicoletti is a full professor of pharmacology at the University Sapienza of Rome School of Medicine; head of the Lab of Molecular Neuropharmacology, IRCCS Neuromed, Pozzilli, Italy; director of the Residence School in Clinical Pharmacology and Toxicology, University of Rome "Sapienza", research supervisor of the Prenatal Stress Team, Glycobiology Unit, University of Lille 1, France. He is among the top world scientists in the field of metabotropic glutamate receptors. He received a number of fundings for different projects, such as Telethon 1999, a project in collaboration with Dr. Antonio De Blasi (Istituto Mario Negri Sud) entitled: "Molecular Determinants of Metabotropic Glutamate Receptor Signalling in Cerebellar Motor Disorders". He has vast teaching experience. Besides, he was also associated with different drug companies such as GSK, Roche, Novartis, Pfizer, etc. He has been a member of different scientific societies, and he organized a number of international meetings. He has been a referee in a number of journals, such as Neuropharmacology, Proceedings of the National Academy of Science USA, Journal of Neurochemistry, Journal of Neuroscience, Neuroscience, Journal of Pharmacology and Experimental therapeutics, Molecular Pharmacology, etc. He has been involved in more than 500 scientific publications. Orcid Scopus RsearcherId
Honorary Advisory Board cn_ebm_salt_001 Salt Thomas E. Institute of Ophthalmology University College London London UK

Professor Tom Salt obtained his Degrees from The Universities of Cambridge and Bristol, is co-founder and Director of Neurexpert Ltd, and Emeritus Professor at University College London. He has worked in the pharmaceutical industry, and acted as a consultant and adviser to industry. Professor Salt's research encompasses the pharmacology of neurotransmitters in relation to the sensory system systems, and more recently the functional consequences of neurodegeneration. He has published over 200 research and review papers, and is a member of several editorial boards. Orcid Scopus RsearcherId
Co-Editor-in-Chief Calabrese Vittorio Department of Biomedical and Biotechnological Sciences University of Catania Catania Italy Orcid Scopus RsearcherId cn_ebm_Caraci_001 Caraci Filippo Department of Drug and Health Sciences University of Catania Catania Italy

Prof. Caraci graduated MD in 2001 and he got his PhD degree in Neuropharmacology in 2009 at University of Catania. In March 2021 he was appointed Associate Professor in Pharmacology at University of Catania and Visiting Professor at University of Bordeaux in 2016/2017 as winner of the Visiting Scholar Grant 2016/2017. Prof. Caraci has worked in the field of drug discovery in depression, Alzheimer’s disease and Down Syndrome with the aim to identify new pharmacological targets. Prof Caraci has been studying the physiology and pharmacology of TGF-ß1 and its role in the pathophysiology of cognitive dysfunction in AD and Down Syndrome. Orcid Scopus RsearcherId
Fineschi Vittorio Department of Anatomical, Histological, Forensic and Orthopaedic Sciences Sapienza University of Rome Roma Italy Orcid Scopus RsearcherId Martinotti Giovanni Department of Neuroscience, Imaging, and Clinical Science University of G. d'Annunzio Chieti and Pescara Chieti Italy

Dr. Giovanni Martinotti is an associate professor at the University "G. d'Annunzio" Chieti-Pescara, Italy, scientific director of the SRP Villa Maria Pia, Rome, and head of the Emerging Drugs and Brain Stimulation Unit, Department of Neuroscience, Imaging, Clinical Sciences, the Institute for Advanced Biomedical Technologies, Chieti. He studied medicine at the Università Cattolica del Sacro Cuore (Rome), with specialization in psychiatry, followed by a PhD in neuroscience. His postgraduate research focuses on addiction psychiatry, with specific interests in treatment-resistant depression, dual diagnosis, complications and sequelae of addiction, pharmacological treatment of addictive disorders, brain stimulation techniques, novel psychoactive substances, and psychedelics. He has clinical experience in the UK, Spain and Brazil. He has authored a number of scientific manuscripts. He was the president of the Young Section of the Italian Psychiatric Association (2012-2020) and, since 2015, he has been the secretary of the World Psychiatric Association (WPA), a section of Ecology, Psychiatry & Mental Health. Scopus RsearcherId
cn_ebm_Steeve-thany_001 Thany Steeve H. Biochemistry and Biology Universite d'Orleans Orleans France

Prof. Steeve Thany completed his Ph.D. in neuroscience behavior and cognition at the University of Toulouse 3 Paul Sabatier, France, in 2004. He joined the University of Angers as an assistant researcher and lecturer in 2004 and then assistant professor in 2005. In 2012, he worked as an associate professor at the University of Florida, Emerging Pathogens Institute (Gainesville, Florida) under the supervision of Prof. Jeff Bloomquist. In 2014, he was hired as a full professor at the University of Orleans (France), the Department of Biochemistry and Biology. Prof. Thany is currently the Chair of the French National Council for the Universities in Neuroscience (CNU 69). Professor Thany’s lab focuses on 1) characterizing the pharmacological properties of insect native neuronal nicotinic acetylcholine receptors, including their subunit composition and functional properties in comparison to mammalian nicotinic acetylcholine receptors and 2) understanding the intracellular pathways regulating the pharmacological properties of native nicotinic acetylcholine receptors. The research combines electrophysiology, molecular biology, and calcium imaging. Orcid Scopus RsearcherId
Country Editor(s) cn_ebm_Bargiotas-sh_001 Bargiotas Panagiotis Sleep Wake Epilepsy Center and Department of Neurology University of Bern Bern Switzerland

Panagiotis Bargiotas is a medical doctor and physician scientist who performs clinical work and research. Currently, he is an Assistant Professor and Faculty member at the Department of Neurology of the Medical School of the University of Cyprus, Nicosia, Cyprus. He received his clinical training and developed doctoral and postdoctoral work at the Universities of Heidelberg (Germany) and Bern (Switzerland). His current research work broadly concentrates on sleep and motion - more specifically, on the neurobiology of sleep-wake disturbances in patients with Parkinson’s disease, neurodegenerative disorders and stroke. Orcid Scopus RsearcherId
cn_ebm_david_001 Brooks David J. Department of Brain Sciences Imperial College London London UK

Dr. Brooks has obtained his Ph.D Degree and he is a Member of (NECTAR - 1996-1999), EU Biomed2 consortium, 1996 - 1999 Dr. Brooks is Hartnett Professor of Neurology in the Department of Medicine, Imperial College, London. His research involves the use of positron emission tomography and magnetic resonance imaging to diagnose and study the progression of Alzheimer’s and Parkinson’s diseases in life and to validate imaging biomarkers for therapeutic trials. Research Areas: Parkinson’s disease, Neurolog, Alzheimer's disease, Sleep behavior disorder. Orcid Scopus RsearcherId
cn_ebm_Citraro_001 Citraro Rita Department of Health Sciences Università degli studi Magna Graecia di Catanzaro Catanzaro Italy

Prof. Rita Citraro is a Pharmacology Professor. She graduated in Biological Sciences and completed Ph.D. in Pharmaceutics Sciences from the University of Catanzaro (Italy) and Post Doc from the Radboud University Nijmegen (the Netherlands). She did a lectureship at the University of Catanzaro in 2012 and became Associate Professor in Pharmacology at the School of Medicine of the same University in 2019. She is the Director of the School of Specialization in Pharmacology and she has an active role in undergraduate and postgraduate teaching in Pharmacology. Her research focus is on the Pharmacology and physiopathology of Epilepsies, the Discovery of new potential anticonvulsant drugs, Comorbidity of Epilepsy with neuropsychiatric diseases, Clinical efficacy and safety of Antiepileptic drugs, Neurodegeneration of the Central Nervous System and related pharmacological targets. Orcid Scopus RsearcherId
cn_ebm_scarselli-m-sa_001 Scarselli Marco Department of Translational Research and New Technologies in Medicine and Surgery University of Pisa Pisa Italy

Professor Marco Scarselli did his Ph.D in Neuropsychopharmacology from the University of Pisa (2003). He has worked as a Research Fellow at the Lab of Molecular Pharmacology, NIDDK, NIH (2003-2008) and as Junior Leader at the Lab of Nanoscale Biology of EPFL, Switzerland (2008-2011). Then, he moved back to the University of Pisa as Assistant Professor and from 2017 he is working as Associate Professor of Pharmacology. He has received national and international grants (e.g. Swiss National Science Foundation), and published many papers in the field of neuropharmacology in journals with high impact factor, such as Nature Methods, PNAS, Molecular Pharmacology, Current Neuropharmacology, European Neuropsychopharmacology and Pharmacology & Therapeutics. He has received an Award (Guglielmo Scarlato) for his scientific contribution from the Italian Parkinson Society. Orcid Scopus RsearcherId
cn_ebm_teruel-a_001 Teruel Albert Fernández Department of Psychiatry & Forensic Medicine Autonomous University of Barcelona Barcelona Spain

Prof. Alberto Fernández-Teruel is Associate Professor at the Department of Psychiatry & Forensic Medicine (Medical Psychology Unit) of the Universidad Autónoma de Barcelona (UAB) and Director of the Animal Research Laboratory of this Unit (“Animal and Human models of mental disorders” research group) since 2004. He received his PhD from UAB in 1989, and developed pre- and postdoctoral work at the University of Cagliari (Italy) and the ETH-Zentrum (Zürich, Switzerland) and the University of Cagliari, where he has also been Visiting Professor/Scientist. He has published over 150 peer-reviewed articles. Part of his research focuses on neurogenetics, quantitative genetics and neurobiology of anxiety, schizophrenia-relevant models, and the impact of early experience in these animal models. Orcid Scopus RsearcherId
Section Editors Neuropsychopharmacology cn_ebm_Agorastos-sh_001 Agorastos Agorastos School of Medicine Aristotle University of Thessaloniki Thessaloniki Greece

Dr. Agorastos is Assist. Professor of Psychiatry at the Aristotle University of Thessaloniki and International Partner of the VA Center of Excellence for Stress and Mental Health (CESAMH) in La Jolla, San Diego, CA, USA. He received his MD at the Medical University of Vienna, completed his doctorate, clinical training and professorial thesis at the University of Hamburg, his MSc in Affective Neuroscience at the Universities of Maastricht and Florence and his Postdoc Fellowship at USCD. Fields of expertise include stress- and trauma-related disorders. Orcid Scopus RsearcherId
cn_ebm_Allegri_001 Allegri Massimo Pain therapy Department Policlinico of Monza Hospit Monza Italy

Dr. Massimo Allegri is head of the Pain therapy Department Policlinico of Monza Hospital. Monza Italy. He is FIPP certified and author of more than 100 peer reviewed articles. His H index is 22. He received funds of more than 10 millions Euro for his research in genetics and pain. His research and clinical interests are analgesics, low back pain, pain in sport medicine and regenerative medicine.

Analgesics Orcid Scopus RsearcherId
cn_ebm_ashraf_001 Md Ashraf Ghulam King Fahd Medical Research Center King Abdulaziz University Jeddah Saudi Arabia

Dr. Ghulam Md Ashraf currently working as Associate Professor at King Fahd Medical Research Center, King Abdulaziz University, Saudi Arabia. He received his PhD in Biochemistry from Aligarh Muslim University (India) in 2010. Dr. Ashraf has been involved in 14 research projects funded by various agencies of Saudi Arabia, and is a member of renowned professional associations and organizations. He has published 239 articles (total citations: 3301 h-index: 27, i10-index: 89) in journals and books of international repute. Dr. Ashraf is also involved in editorial capacity in many reputed journals, like PLOS one, Scientific Reports, Frontiers in Neuroscience, Current Proteins and Peptides, Journal of Proteomics, to mention a few. Dr. Ashraf’s prime field of research is neurology, currently focusing on understanding the molecular and behavioral mechanism of effects of anti-diabetic drugs in pyschotic and dementia conditions. His lab is currently investigating the effect of anti-diabetic drugs in effective reversal of anti-psychotic drugs induced weight gain in psychosis conditions in Wistar rats. Dr. Ashraf’s lab is also investigating the effect of anti-diabetic drugs in animal models of psychosis and Alzheimer’s disease.

Neuropyschopharmacology Orcid Scopus RsearcherId
cn_ebm_Bagatini-sh_001 Margarete D. Bagatini Department of Biological Sciences Universidade Federal da Fronteira Sul Chapecó Brazil

Dr. Margarete Dulce Bagatini is an associate professor at the Federal University of Fronteira Sul/Brazil. She has a degree in Pharmacy and Ph.D. in Biological Sciences: Toxicological Biochemistry. She is a member of the UFFS research advisory committee and a member of the Biovitta Research Institute. She is currently the leader of the research group: Biological and Clinical Studies in Human Pathologies, professor of the postgraduate program in Biochemistry at UFSC, and postgraduate program in Biomedical Sciences by UFFS. She acts mainly on the following topics: oxidative stress, purinergic system, and human pathologies being a reviewer of several international journals and books. Oxidative Stress and Neurodegenerative Diseases Orcid Scopus RsearcherId
Oxidative Stress and Neurodegenerative Diseases cn_ebm_Barnstable-sh_001 Barnstable Colin J. Department of Neural and Behavioral Sciences Penn State College of Medicine State College, PA USA

Prof. Colin Barnstable received D. Phil. in genetics from Wolfson College, Oxford. He joined the laboratory of Dr. Torsten N. Wiesel in the Department of Neurobiology, Harvard Medical School as a Damon Runyon-Walter Winchell Cancer fund fellow. In 2006, he became the professor and founding chair of the Department of Neural and Behavioral Sciences at Penn State College of Medicine in Hershey, PA. His work has covered many aspects of the molecular regulation of retinal development as well as structural aspects of visual cortex and changes during a number of neurodegenerative conditions. His recent work has focused on the role of the epigenome in regulating retinal development and degeneration and on the molecular mechanisms regulating oxidative stress in a number of degenerative diseases. Dr. Barnstable's work has appeared in many publications and has been cited over 23,000 times. He has also served as co-editor of a series of books on ophthalmology published by the Humana Press imprint of Springer. He has served on the editorial boards of multiple journals including Experimental Eye Research, Journal of Molecular Neuroscience, Journal of Neuroscience, Journal of Neurochemistry, Journal of Ocular Biology, Diseases and Informatics, Molecular Neurobiology, and Neural Regeneration Research. Orcid Scopus RsearcherId
Oxidative Stress and Neurodegenerative Diseases cn_ebm_Bilal-cig_001 Cig Bilal Department of Physiology Kirsehir Ahi Evran University Kırşehir Turkey

Bilal CIG received his Bachelor of Science degree from Firat University, Faculty of Engineering, Department of Chemical Engineering in Elazig, Turkey, in 2009. He received his Master's degree in Biophysics from Suleyman Demirel University Health Sciences Institute in Isparta in 2014, and then his PhD in Neurosciences in 2018. He worked as a research assistant at the same university until 2020. Presently, he is working as an associate professor in Kirsehir, Kirsehir Ahi Evran University Medical University, Faculty of Medicine, Department of Physiology. He is still an editor in journals such as Frontiers in cell and Developmental Biology, Frontiers in Physiology, Biomed Research International, Ahi Evran Medical Journal. Most of his publications are in the field of TRP and neuroscience. Orcid RsearcherId
cn_ebm_Coizet_001 Coizet Véronique Institut des Neurosciences de Grenoble Centre de Recherche Inserm Université Grenoble Alpes Grenoble France

Dr. Coizet completed his PhD in the Laboratory of Behavioral and Cognitive Neuroscience (LN2C, UMR 752, University Louis Pasteur, Strasbourg). He then became a post-doctoral research assistant with Peter Redgrave and Paul Overton in Sheffield (UK). His research focused in large part on the basal ganglia and related structures, especially sensori-motor structures from the brainstem. He was appointed to an INSERM permanent research position at the Grenoble institute of neuroscience in 2009. His research project focused on the anatomical and functional link between the sensori-motor structures from the brainstem and the subthalamic nucleus. In Grenoble, he established multi sites in vivo single unit and field potential recordings within this network and equipped the laboratories for all kinds of sensory stimulations (visual, audition, pain …). These electro-physiological techniques are routinely combined with neuroanatomical tract tracing and immuno-histochemistry. He took advantage of his new working environment favoring clinical and pre-clinical research to study this network in Parkinson’s disease and animal models of this disease. This research combines electrophysiology with neuroimaging (functional magnetic resonance imaging) via well-established collaborative national and international collaborators. Basal Ganglia and Motor Disorders Orcid Scopus RsearcherId
cn_ebm_Conti-sa_001 Conti Fiorenzo Department of Experimental and Clinical Medicine Università Politecnica delle Marche Ancona Italy

Fiorenzo Conti did M.D. in 1980 from University of Ancona School of Medicine. He was a Postdoctoral fellow in the Department of Anatomy, University of North Carolina, USA. He is a full Professor of Physiology, at the University of Ancona School of Medicine, Ancona, Italy since 1994. His main research activity is focused on the anatomical and molecular organization of glutamatergic and GABAergic synapses in cerebral cortex, with an emphasis on plasma membrane and vesicular transporters, on cortical plasticity, and on the analysis of synaptic dysfunction in neuropsychiatric diseases. Since 2012, he is the Director of the Center for Neurobiology of Aging, INRCA IRCCS, Ancona. He remained the President of the Italian Society for Neuroscience (2016-2017), and of the Italian Society of Physiology (2020-2023). He achieved a number of awards and honors and besides, he is the author or coauthor of a number of scientific papers and books.

Neurosciences RsearcherId
Neurotransmitters cn_ebm_Diao-Jia-sh_001 Diao Jiajie Department of Cancer Biology University of Cincinnati Cincinnati. OH USA

Dr. Jiajie Diao received his Ph.D. in December 2010 in Physics from University of Illinois at Urbana-Champaign under the supervision of Prof. Taekjip. Then he worked with Prof. Axel T. Brunger in Stanford University & HHMI as a postdoctoral fellow during 2011-2015. Around the end of 2015, he started his own research lab at the Department of Cancer Biology, University of Cincinnati College of Medicine. His main research interest is using advanced biophysical tools to study membrane biophysics. Orcid Scopus RsearcherId
cn_ebm_Fazio-sa_001 Neurosciences Fazio Francesco Department of Psychiatry University of California San Diego ,CA USA

Dr. Francesco Fazio completed his Ph.D. in Pharmacology from the University Sapienza of Rome, Italy, in 2011 and was a research collaborator in Neuropharmacology Department of Neuroscience of I.R.C.C.S. Neuromed. In 2019, he joined the Department of Neuroscience at the Albert Einstein College of Medicine of New York as faculty associate. In 2021, he joined the Department of Psychiatry at the University of California, San Diego (UCSD) as a visiting scientist and soon after as assistant project scientist under the supervision of Prof. Andre Der-Avakian. He started his scientific career studying metabotropic glutamate receptors and their role within the immune system. Later, he focused on unorthodox metabolites of tryptophan metabolism along the kynurenine pathway, discovering that both xanthurenic and cinnabarinic acids interact with metabotropic glutamate receptors and that they play a role in schizophrenia. Currently, he studies translational animal models of anhedonia at the UCSD.

Orcid Scopus RsearcherId
Psychotic Disorders cn_ebm_Gonzalez-Rodriguez_001 Alexandre González-Rodríguez Department of Mental Health Autonomous University of Barcelona Bellaterra Spain

Dr. Alexandre González-Rodríguez got his bachelor’s degree in Medicine at the University of Barcelona in 2008. He earned residency in Psychiatry (2009-2013) at the Department of Psychiatry and Psychology, Hospital Clinic of Barcelona. His doctoral dissertation (University of Barcelona, 2018) was focused on the Biomarkers of treatment response in postmenopausal women with schizophrenia. He is working at the Partial Hospitalization Program of the Department of Mental Health at the Corporació Sanitària Parc Taulí, Autonomous University of Barcelona. His research interests are gender differences in schizophrenia, hormonal and genetic factors on antipsychotic response in schizophrenia. Scopus RsearcherId
Obsessive-Compulsive Disorder cn_ebm_Hoffman_001 Hoffman Kurt Leroy Centro de Investigación en Reproducción Animal Universidad Autónoma de Tlaxcala Tlaxcala Mexico

Dr. Kurt Leroy Hoffman received a Bachelor of Science degree in Zoology from the University of Wisconsin, Madison, a Doctoral degree in Biology-Neuroscience from the Institute of Neuroscience at the University of Oregon, Eugene, and did postdoctoral work in the laboratory of Dr. W. Ian Lipkin, University of California, Irvine. His work has involved the study of neurobiological and behavioral processes in a variety of model animals, ranging from Manduca sexta (the common tobacco hawkmoth) to the European rabbit, as well as diverse aspects of neurobiology and behavior, including neuronal differentiation, myelination, neuroendocrinology and programmed cell death, reproductive behavior, and animal models for studying obsessive-compulsive disorder and schizophrenia. Scopus RsearcherId
cn_ebm_Huang-Liquan-sh_001 Huang Liquan Institute of Cellular and Developmental Biology Zhejiang University, Zijingang Campus Zhejiang China

Dr. Liquan Huang received his B.Sc. degree from Zhejiang University and M.Sc. degree from the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and M.Phil. and Ph.D. degrees from Yale University. He did his postdoctoral research at Howard Hughes Medical Institute and Mount Sinai School of Medicine of New York University, followed by serving as a faculty member at the University of Pennsylvania-affiliated Monell Chemical Senses Center. Currently, he is a professor at the College of Life Sciences Zhejiang University in Hangzhou, China. He has been investigating molecular mechanisms underlying taste and olfactory sensations and made some significant findings. Neurotransmitters Orcid Scopus RsearcherId
cn_ebm_h-Khan-sh_002 Khan Haroon Department of Pharmacy Abdul Wali Khan University Mardan Pakistan

Dr. Khan is the Full Professor at the Department of Pharmacy, Abdul Wali Khan University Mardan (AWKUM), Pakistan. In 20 years of his professional experience, he has significantly contributed to the teaching and training of pharmacy graduates and pharmacy-related services. Dr. Khan remained a member of AWKUM syndicate, executive member of the Pharmacy Council of Pakistan KP and editorial member of more than 15 journals. He is the author of 226 articles including editorial, review, research and four books including one by Elsevier. Moreover, several post-graduate scholars are working under his supervision. Neuropathic pain Orcid Scopus RsearcherId
cn-t-li-sh_001 Li Tianfu Department of Neurology Sanbo Brain Hospital, Capital Medical University Beijing China

Prof. Tianfu Li graduated as MD from Taishan Medical University, received a Ph.D. from Shanghai Medical College of Fudan University and Postdoctoral training in Legacy Clinical Research Institute in USA respectively. The major research work by Prof. Li and his group are on the pre-surgery evaluation for pharmacoresistant epilepsy and neuromodulation in treating pharmacoresistant epilepsy. He is the Vice director of Epilepsy Center, Sanbo Brain Hospital, Capital Medical University. Prof. Li has published a few articles in some important scientific journals including Journal of clinical investigation, Brain, Glia, Brain pathology, Nature communication, and Nature photonics. He serves as an associate editor for Neuropsychiatry, section editor for Current Neuropharmacology and guest editor for Frontiers in Neurology. Epilepsy Scopus RsearcherId
cn_ebm_Xingbao-li-sh_001 Li Xingbao Department of Psychiatry & Behavioral Sciences Medical University of South Carolina Charleston, SC USA

Dr. Xingbao Li is an Assistant Professor in the Department of Psychiatry and Human Behavior at the Medical University of South Carolina. He received his M.D. and M.S. in China and his M.S.C.R. in the U.S.A. US NIH has awarded Dr. Li in the development of addiction therapy. He has published more than 60 papers in peer-reviewed professional journals. He has also served as a reviewer for NIH Study Sections. His research interests include transcranial magnetic stimulation (TMS), functional MRI, and combining TMS and functional MRI techniques in neuropsychiatry, especially in depression and substance abuse. Brain Disorders Scopus RsearcherId
cn_ebm_Li-ze_001 Li Zezhi Department of Psychiatry The Affiliated Brain Hospital of Guangzhou Medical University Guangzhou China

Prof. Zezhi Li received MD. and Ph.D. from Shanghai Jiao Tong University School of Medicine. He completed postdoctoral training at the National Institutes of Health (NIH). Prof. Li mainly focuses on neuropsychiatric disorders, especially neuropsychopharmacology. He is a professor of the Affiliated Brain Hospital of Guangzhou Medical University. Prof. Li has published a few articles as the first author or corresponding author in some important scientific journals including Journal of clinical investigation, Journal of Neurology, Neurosurgery, and Psychiatry, Schizophrenia Bulletin, and British Journal of Psychiatry.

Neuropsychiatric Disease Orcid Scopus RsearcherId
cn-liang-p-sa_001 Liang Peipeng School of Psychology Capital Normal University Beijing China

Dr. Peipeng Liang received a Ph.D. from Beijing University of Technology in 2009. He joined the Radiology department of Xuanwu Hospital as a Post-Doctoral Research Fellow in 2009 and became a research faculty in 2011. He now is a professor of the School of Psychology, Capital Normal University since 2018. His research direction is cognitive neuroscience and neuroimaging, including cognitive neural mechanism of human reasoning, the construction and application and human brain atlas, etc. Neuroimaging Scopus RsearcherId
cn_ebm_Mansueto-ge_001 Mansueto Gelsomina Department of Advanced Clinical and Surgical Sciences University of Campania "Luigi Vanvitelli" Naples Italy

José-Antonio Munive currently works at the Microbiology Sciences Center (Sciences Institute) of the Benemérita Universidad Autónoma de Puebla, in Puebla, Mexico. His area of expertise covers microbial ecology, biodiversity, genetic diversity, taxonomy of rhizobia, genomics and evolution. José-Antonio Munive is a professor of the graduate program in Microbiology (Master’s, Doctoral). Courses taught in graduate programs include: Bioinformatics, Biotechnology, Microbial genetics and Microbiology. José-Antonio Munive has a Ph.D. in Microbial Ecology from the University Claude Bernard Lyon, France.

Oxidative Stress and Neurodegenerative Diseases Orcid Scopus RsearcherId
cn_ebm_Constantinos-Marios-Mikelis_001 Vascular Physiology Constantinos Marios Mikelis Department of Pharmacy University of Patras Patras Greece

Dr. Mikelis is Associate Professor in the Department of Pharmacy, University of Patras, in Greece and Adjunct Associate Professor in the Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center (TTUHSC), in Amarillo, TX, USA. He has worked at the National Institute of Dental and Craniofacial Research (NIDCR), at the National Institutes of Health (NIH). In 2014, he became Assistant Professor in the School of Pharmacy at TTUHSC, and was promoted to Associate Professor with tenure in 2021. In the same year, he moved to the University of Patras, where he is working to date. Orcid Scopus RsearcherId
cn_ebm_Sergey-Olegovich_001 Medicinal chemistry of neurodegenerative disorders Bachurin Sergey Institute of Physiologically Active Compounds Russian Academy of Sciences (IPAC RAS) Chernogolovka Russian Federation

Professor Sergey Bachurin received the Ph.D. degree in 1980 from Moscow State University. From 2006 to 2018, he remained the Director of the Institute of Physiologically active Compounds RAS. In 2003, he was elected as a member of the Russian Academy of Sciences. His research activity is related to the discovery of novel agents for neurodegenerative diseases treatment, in particular for Alzheimer's disease. He is the author of more than 250 articles in peer-reviewing journals and about 40 patents. His h-index is 33. Prof. Bachurin was an invited lecturer at the University of California (San Francisco), and at Tufts University (Boston).

Orcid Scopus
Neurotoxicity cn_ebm_Palikaras_001 Palikaras Konstantinos Department of Physiology National & Kapodistrian University of Athens Athens Greece

Dr. Konstantinos Palikaras is Assistant Professor of Experimental Physiology at the Medical School of the National and Kapodistrian University of Athens, in Athens, Greece. He is a molecular biologist who has great experience in energy metabolism, autophagy, and aging. His research focuses on studies of autophagy, mitophagy, and cellular homeostasis investigating the role of energy metabolism. His main interests are the molecular mechanisms of necrotic and mitophagic cell death and their interplay between cellular metabolism and aging, and the development of novel genetic tools for biomedical research. For his scientific accomplishments, Konstantinos Palikaras has received several notable scientific prizes including a “Fotis Kafatos” Award for excellence in biology from Hellenic Society of Bioscientists, Research Grant from Hellenic Foundation for Research and Innovation (HFRI), AXA Research Fund Post-doctoral fellowship, Bodossaki Foundation Post-doctoral fellowship, DeLill Nasser Award for Professional Development in Genetics from Genetic Society of America and Manasaki Doctoral Fellowship from the University of Crete. Orcid Scopus RsearcherId
cn_ebm_Pezzini-sa_001 Stroke Pezzini Alessandro Department of Clinical and Experimental Sciences Neurology Clinic University of Brescia Brescia Italy

Alessandro Pezzini graduated cum laude in Medicine and Surgery from the University of Brescia, Italy in 1995. In 2002, he became a specialist in Neurology, cum laude, at the same University. He was Research Fellow at the University of Heidelberg in 2001-2002 and then at the University of Munich, Germany, in 2004. In 2007, he was appointed Assistant Professor of Neurology at the University of Brescia in 2010, and Associate Professor in 2015. He is a stroke neurologist at the Neurology Clinic, University of Brescia, Italy. He is member of the Editorial Board of 15 international journals, has served as peer reviewer to over 50 international journals. He is also a member of the Italian Neurological Association (SIN), the World Stroke Organization (WSO), and Fellow of the European Stroke Organization (FESO). Dr. Pezzini is actively involved in international research projects on cervical artery dissections and cerebral non-atherosclerotic vasculopathies, heart-brain interactions, acute ischemic stroke treatment, and intracerebral hemorrhage. He is also a founding member of the Cervical Artery Dissection and Ischemic Stroke Patients (CADISP) network, and the multicentric project Reversible Cerebral Vasoconstriction Syndrome International collaborative study (REVERCE). He authored or co-authored more than 225 papers in peer-review journals, 1 monograph and 14 book chapters.

Orcid Scopus RsearcherId
cn_ebm_Pontieri-sa_001 Preclinical and clinical pharmacology of basal ganglia disorders Pontieri Francesco E. Department of Neuroscience, Mental Health & Sensory Organs Sapienza University of Rome Rome Italy Orcid Scopus RsearcherId cn_ebm_Rosati_001 Rosati Luigi Department of Biology Università degli Studi di Napoli Federico II Naples Italy

Dr. Rosati is a Comparative Anatomy and Cytology Researcher at the University of Naples (Italy), in 2014 he received a PhD in Advanced Biology at the University of Naples. In 2016 he was awarded the prize by Italian Society for Microscopical Sciences. In 2017 he was awarded the "Mariolina Capano" prize by the National Society of Sciences, Letters and Arts in Naples, for studies on reproduction control mechanisms. In 2018 he was awarded a Grant at the 64th GEI Conference. His main research interests are 1) the role of local factors (neuropeptides and steroidogenesis enzymes) in spermatogenesis control in the vertebrates 2) the use of vitellogenin as a biomarker of environmental pollution in aquatic organism 3) study of endocrine-disrupting chemicals and drugs in the vertebrate reproduction. Nueropeptides Orcid Scopus RsearcherId
Mood Disorders cn_ebm_Rosso-Gianluca-sh_001 Rosso Gianluca Department of Neurosciences ‘Rita Levi Montalcini University of Turin Torino Italy

Associate Professor of Psychiatry at Department of Neurosciences ‘Rita Levi Montalcini’, University of Torino, Italy. Clinical activity at Psychiatric Unit of San Luigi Gonzaga University Hospital of Orbassano (Torino), Italy. Lecturer at University of Turin: Medicine and Surgery School and other Degree Courses, Postgraduate School of Psychiatry. Author of over 80 publications on national and international peer reviewed journals. Research interests: mood disorders, clinical psychopharmacology, obsessive-compulsive disorder, short-term psychodynamic psychotherapy. Orcid Scopus RsearcherId
cn_ebm_Scimone-sh_001 Scimone Concetta Department of Biomedical and Dental Sciences and of Morphological and Functional Images University of Messina Messina Italy

Dr. Concetta Scimone is researcher at Department of Biomedical and Dental Sciences and of Morphological and Functional Images, at University of Messina, Messina, Italy, and at Department of Biomolecular Strategies, Genetics and Avant-Garde Therapies, I.E.Me.S.T, in Palermo (Italy). She obtained a Master’s Degree in “Biotechnology for Health” at the University of Messina and completed her PhD in “Biology and Cellular Biotechnology”. She is a member of the Organizing committee and also a teaching staff of the Master in “Science-applied Bioinformatics and Biostatistics”. Her main research fields include brain microvasculature development and defective angiogenesis-related disorders, cerebral cavernous malformations and brain arteriovenous malformations. Dr. Scimone’s expertise include: genetics, molecular genetics, molecular biology, cell biology, genomics, transcriptomics, epigenetics, next generation sequencing analysis, population genetics and regulation of gene expression. Blood-Brain Barrier Orcid Scopus RsearcherId
cn-Shi-y-sh_001 Shi Yuan Department of Neonatology Chongqing Medical University Chongqing China

Prof. Yuan Shi graduated as MD from Third Military Medical University and received a Ph.D. from Chongqing Medical University respectively. The major research work by Prof. Yuan Shi and his group are on neonatal respiratory diseases and brain injury. He is the chief of Department of Neonatology, Chongqing Medical University. In 2019, this department admitted over 12,000 newborn infants, which is indicated to have the biggest neonatal patient numbers in China. Prof. Shi has published a few articles in some important scientific journals including Pediatrics, Chest, JAMA Pediatrics, Journal of Pediatrics, Archives of Disease in Childhood, and Neonatology. He serves as an associate editor for BMC Pediatrics, section editor for Current Neuropharmacology, guest editor for Frontiers in Pediatrics and CNS & Neurological Disorders - Drug Targets. Pediatric Neurology Orcid Scopus RsearcherId
cn_ebm_Stefano-sa_001 Neuroendocrinology Stefano George B. Center for Cognitive and Molecular Neuroscience, First Faculty of Medicine Charles University Prague Czech Republic

Dr. Stefano (MSc & PhD Fordham University; Certificate in Mammalian Radiation, Oak Ridge Associated Universities; DR HC, St Elizabeth's University) served at the State University of New York (SUNY) as the Director/Founder of the Neuroscience Research Institute. He was awarded a Distinguished Professor rank, as well as CASE Professor at the New York State. He served as Vice Chair of the Research Foundation of SUNY Board of Directors, Vice Chair of the Executive Committee and Chair of the Research Committee. He has published over 500 peer reviewed reports and has 9 patents and grant funding for over 29 years (NIMH, NIDA, NSF and Fogarty International Center). Currently, he is at the Center for Cognitive Molecular Neuroscience, First Medical Faculty Psychiatry, Charles University, Prague, Czech Republic. His research focus is on the evolutionary conserved chemical messengers (e.g., opioids), including viral compromised host processes (brain).

Orcid Scopus RsearcherId
cn_ebm_Tao_001 Tao Feng Department of Biomedical Sciences Texas A&M University, College of Dentistry Dallas, TX United States

Dr. Feng Tao is an Associate Professor in the Department of Biomedical Sciences at Texas A&M University College of Dentistry. Dr. Tao has published more than 50 papers in peer- reviewed professional journals. He is serving as an editorial board member for 6 professional journals and he is also an invited reviewer for NIH Study Sections, NSF-sponsored Pilot Funding, Britain Israel Research and Academic Exchange Partnership Regenerative Medicine Initiative, Wings for Life−Spinal Cord Research Foundation in Austria, Department of Veterans Affairs Rehabilitation Research and Development Service Spinal Cord Injury Neuropathic Pain Panel, and The French National Research Agency in France.

Neuropharmacology of Cognition and Integrative Neurosciences Orcid Scopus RsearcherId
cn_ebm_Domenico-Tricarico_001 Neurotrophic Factors Tricarico Domenico School of Pharmacy Hospital Università degli studi di Bari Aldo Moro Bari Italy

Dr. Domenico Tricarico is the Prof. of Pharmacology & Toxicology at the University of Bari, Italy. He did Ph.D. in Biochemistry and Cellular Pharmacology. He remained the Director of the School of Pharmacy Hospital Pharmacologist of the Ethics Committee for Clinical Trials of the University-Hospital Polyclinic-ASL BA, Ethics Committee for Clinical Trials of the Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari, Italy. He has expertise in Molecular target characterization: pharmacology of ion channels in neuromuscular disorders, neurodegeneratives, cancers and diabetes, Risk/benefit analysis of experimental drugs and post-marketing surveillance and Development of innovative formulation of drugs/natural extracts of therapeutic interest. Scopus RsearcherId
cn_ebm_Uchida_001 Uchida Kentaroo School of Medicine Kitasato University School of Medicine Sagamihara Japan

Dr. Kentaro Uchida is a lecturer at the Kitasato University School of Medicine in Sagamihara, Kanagawa, Japan. He is a member of National Institute of Science and Technology Policy (NISTEP). Fields of expertise include pain, musculoskeletal disorders, neuropeptides, immunology and regenerative medicine. He is the editor and reviewer of several international journals.

Neuropeptides Orcid Scopus RsearcherId
cn_ebm_Xiao_001 Xiao Jianbo Faculty of Food Science and Technology University of Vigo Vigo Spain

Dr. Jianbo Xiao is current a full professor of Faculty of Food Science and Technology, University of Vigo (Spain). He received PhD degree in nutrition from Okayama Prefectural University (Japan) in 2009. He worked as a Postdoc supported by AvH foundation at University of Würzbug, Germany (April 2013-May 2015) and then worked as an assistant professor in University of Macau (October 2015-December 2020). Dr. Xiao has been selected as Clarivate Analytics Highly Cited Researchers (2016, 2017, 2019 and 2020). His research is focusing on dietary polyphenols. He has accepted and published more than 300 peer reviewed papers including Nature Reviews Drug Discovery, Seminars in Cancer Biology, Biotechnology Advances, Medicinal Research Reviews, Trends in Food Science & Technology, Critical Reviews in Food Science and Nutrition, Acta Pharmaceutica Sinica B, Journal of Advanced Research, Food Chemistry, Food and Chemical Toxicology, Molecular Nutrition and Food Research, Journal of Agricultural and Food Chemistry and so on (Scopus citation: 8698, H-index 49; Google citation: 11386, H-index 56). He also works as the chairman to organize ISPMF2015, 2-ISPMF (2017), 3-ISPMF (2018), and 4-ISPMF (2020). Dr. Xiao has given 5 plenary lectures, 12 invited lectures and 15 oral presentations on international conferences. Dr. Xiao has hosted more than 12 research grants and since 2009. Dr. Xiao is the expert Reviewer of European Science Foundation, UK Diabetes Foundation (UK), Natural Science Foundation of China (China), the Italian Ministry for Education, University and Research (Italy). Dr. Xiao was elected to full membership of Sigma Xi Scientific Research Honor Society (USA).

Pharmacology of natural products Orcid Scopus RsearcherId
cn_ebm_yang_001 Yang Jinn-Moon Department of Biological Science and Technology National Yang Ming Chiao Tung University (NYCU) Hsinchu Taiwan

J.M. Yang research areas include computational drug discovery, structural bioinformatics, and computational systems biology. He has published over 100 SCI papers and some of them in high-impact journals, such as Nature Communications, ACS Nano, Genome Biology, and Nucleic Acids Research. His primary goal is to study drug-protein-pathway-disease relationships in a cell. His h-index is 36 and the total number of citations is over 4,800 based on statistics in Google scholar. His team has developed a molecular docking tool (GEMDOCK and iGEMDOCK), which is one of the most widely used tools and cited over 800 times.

Computational Drug Design Orcid Scopus RsearcherId
cn_ebm_Wangyuan-sh_001 Zou Wangyuan Department of Anesthesiology Central South University Changsha China

Dr. Zou is a Professor in the Central South University (CSU) and Vice Director of the department of Anesthesiology in Xiangya Hospital. After graduating from Xiangya Medical College he received M.D. and Ph.D. in anesthesiology from Xiangya Hospital of CSU. In 2014, he completed the postdoctoral research at the Solomon H. Snyder, Department of Neuroscience, Johns Hopkins University School of Medicine. In 2013, he was appointed as an Assistant Professor at the department of Anesthesiology of Xiangya Hospital, and then became a Full Professor in 2018. A major goal of his laboratory is to elucidate mechanism of neuropathic pain and morphine tolerance. Analgesics Orcid Scopus RsearcherId
Editorial Board Members cn_ebm_abraini_001 Abraini Jacques H. Department of Anesthesiology University of Caen - Basse Normandie Caen France

J. H. Abraini is the President of the International Group for High Pressure Biology (IGHPB). He is a Professor of Neuroscience at the University of Caen Medical School (France) and at Laval University Medical School , Department of Neuroscience and Psychiatry (QC, Canada ). He has published many scientific publications and his field of interest are Neuroprotection, Neurotransmission, Gamma-aminobutyric acid neuropharmacological investigations, postsynaptic dopamine receptors. Scopus RsearcherId
cn_ebm_gustav_001 Akk Gustav Department of Anesthesiology Washington University School of Medicine St. Louis, MO USA

Dr. Akk obtained his Ph.D. in Biophysics from the State University of New York at Buffalo. Following postdoctoral training at the Department of Neurology and Neurological Sciences at Stanford University, he joined the Department of Anesthesiology at Washington University School of Medicine, initially as a research associate and then as a faculty member. Dr. Akk is presently an Associate Professor of Anesthesiology and a core member of the Taylor Family Institute for Innovative Psychiatric Research. Gustav Akk is an author of over 70 peer-reviewed publications. Orcid Scopus RsearcherId
cn_ebm_bka-vappa_001 Alldredge Brian K. School of Pharmacy University of California San Francisco, CA USA

Dr. Alldredge is a Professor of Clinical Pharmacy and Neurology at the University of California, San Francisco and he serves as Vice Provost-Academic Affairs . His clinical practice and research interests focus on epilepsy, seizure emergencies, prehospital care, and pharmacogenomics. He participates on invited review groups for the National Institutes of Neurological Disorders & Stroke, and he serves as a reviewer for journals in pharmacy, neurology and medicine. His research has been funded by the National Institutes of Health and professional organizations. Scopus RsearcherId
cn_ebm_araki_001 Araki Wataru Department of Desalination Dis. & Aging National Institute of Neuroscience Tokyo Japan

Dr. Araki received his medical doctor’s degree and Ph.D. degree at Kyoto University in 1985 and 1992, respectively. He had postdoctoral training at the National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan and Massachusetts Institute of Technology, U.S.A. He has been working as a section chief at the National Institute of Neuroscience, NCNP since 1998. He is an author of more than 60 peer-reviewed publications. Orcid Scopus RsearcherId
cn_ebm_arnold_001 Arnold Jonathon C. Department of Pharmacology The University of Sydney, New South Wales Sydney Australia

Jonathon Arnold is an Associate Professor in the Discipline of Pharmacology. He has over 60 publications which have received > 2000 citations (h-index = 25). His research has attracted national and international funding. He regularly reviews grants for the National Health and Medical Research Council, Australian Research Council, the Marsden Fund (New Zealand), the Medical Research Foundation (UK),. Field of Interest: Neuropharmacology; Schizophrenia; Pharmacology; Substance abuse and addiction; Behavioural neuroscience Orcid Scopus RsearcherId
cn_ebm_Atwood_001 Atwood Craig S. Department of Medicine University of Wisconsin-Madison School of Medicine and Public Health Madison, WI USA

Dr. Atwood obtained his Ph.D. in Biochemistry from the University of Western Australia, Perth, Australia. He has held faculty positions at Harvard Medical School and Case Western Reserve University prior to his current appointments as an Associate Professor in the University of Wisconsin-Madison Department of Medicine, and as a Health Science Specialist within the Geriatric Research, Education and Clinical Center at the William S. Middleton Memorial Veterans Administration Hospital, Madison. He has published more than 150 scientific publications, is an inventor on 8 issued U.S. patents and is a top cited author (h-index =45). He has received a number of awards for his teaching and research, including the Zenith Fellows Award from the Alzheimer’s Association. Scopus RsearcherId
cn_ebm_avoli_001 Avoli Massimo Departments of Neurology & Neurosurgery McGill University Montreal, QC Canada

Massimo Avoli is a Physician Scientist who performs research as a Faculty member of the Montreal Neurological Institute of McGill University. He is a Professor in the McGill University's Departments of Neurology & Neurosurgery and of Physiology as well as Professor of Human Physiology in the Department of Experimental Medicine at the Sapienza University of Rome. Dr. Avoli’s main interests are directed to the fundamental abnormalities that lead to the generation of seizures by employing electrophysiological recording in in vivo and in vitro experimental models of epilepsy. In his current research, Dr. Avoli explores the role played by inhibitory and excitatory mechanisms in the synchronicity of neuronal networks of the limbic system, and thus in seizure initiation. He is also addressing the changes in excitability that contributes to epileptogenesis in temporal lobe epilepsy as well as the mechanisms of action of anti-epileptic drugs. Orcid Scopus RsearcherId
cn_ebm_azizi-g-as_001 Azizi Gholamreza Non-communicable Diseases Research Center Alborz University of Medical Sciences Karaj Iran

Gholamreza Azizi received his PhD in Biomedical Sciences at Tehran University of Medical Sciences. He is an investigator in the Non-communicable Diseases Research Center at Alborz University of Medical Sciences. His research focuses is on understanding the immunological mechanisms of immune regulation in patients with primary immunodeficiency and autoimmunity as well as the use of tyrosine kinases inhibitors to reduce inflammation in an animal model of multiple sclerosis. Orcid Scopus RsearcherId
cn_ebm_bahr_001 Bahr Ben A. Biotechnology Research and Training Centre University of North Carolina - Pembroke Pembroke North Carolina, NC USA

Professor Bahr is trained in the fields of chemistry, molecular biology, and neuroscience and is the lead investigator for several grants studying Alzheimer’s disease and other brain disorders. Upon receiving his Ph.D. from University of California–Santa Barbara, Dr. Bahr joined the Center for the Neurobiology of Learning and Memory at University of California–Irvine as a researcher and lecturer. Currently, Dr. Bahr is the William C. Friday Chair and Distinguished Professor at the Pembroke campus of University of North Carolina. He has over 140 publications and several patents and pending patents on first-in-class neuroprotective compounds and their uses. Scopus RsearcherId
cn_ebm_bakalova_001 Bakalova Rumiana Department of Molecular Imaging and Theranostics National Institute of Radiological Sciences (NIRS) Chiba Japan

Dr. Bakalova obtained a doctor (PhD) degree in Biochemistry & Biophysics from the Bulgarian Academy of Sciences, as well as a doctor of science (DSci) degree in Biological Sciences from the Sofia University “St. Kliment Ohridski”, Bulgaria. She has over 180 scientific publications and 12 Japanese patents. The main scientific interests of Dr. Bakalova are in the field of molecular imaging, molecular probe design, drug delivery systems, and nanomedicine. Recent studies are focused on redox-imaging and image-guided redox-modulation in cancer, as well as in nano-theranostics for cancer therapy. Orcid Scopus RsearcherId
cn_ebm_ballerini_001 Ballerini Laura Department of Physiol Pathol University of Trieste Trieste Italy

Laura Ballerini graduated (MD) at the Università di Firenze, Italy in 1988. She was a Postdoctoral fellow (Physiology Department) at UCL (London, UK) from 1991 and later became assistant professor of Physiology at the Biophysics Sector of the International School for Advanced Studies (SISSA-ISAS) of Trieste, Italy in 1995. In 2002 Laura Ballerini became associate professor of Physiology at the Life Science Department, Università di Trieste, Italy, where in 2012 she became full professor of Physiology and from January 2016 to date she is chair professor of physiology at SISSA. She has provided important contribution to the understanding of spinal network physiology, plasticity and development. Recently, she has been working on the interactions between living neurons and micro-nano fabricated substrates or bioactive-composite containing carbon nanotubes. The scientific strategy at the core of these activities is the convergence between nanotechnology, chemistry and neurobiology. Orcid Scopus RsearcherId
cn_ebm_barr_001 Barr Alasdair M. Department of Anesthesiology Faculty of Medicine University of British Columbia Vancouver, BC Canada

Dr. Barr is an Investigator at BC Children's Hospital and Associate Professor, Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, UBC. The central focus of his research is mental health and addictions, with a particular emphasis on psychosis and the medications used in its treatment. Research Areas Schizophrenia/Psychosis, Depression, Animal models, Biological mechanisms, Brain morphology, Clinical trials, Cognition, Drug development, Drug dosing, Drug side-effects , Neuropsychiatry/ Neuropsychology,Neurotransmitters, Psychostimulants. Orcid Scopus RsearcherId
cn_ebm_barbaccia_001 Barbaccia Maria L. Department of Systems Medicine University of Rome Tor Vergata- Medical School Rome Italy

Dr. Maria Luisa Barbaccia obtained a MD degree from the University of Milan, Medical School, Italy. Her research activity, mostly focused on various aspects of neuro-psychopharmacology, was performed at the Institute of Pharmacology of Milan University, Milan-Italy (1979-80), Washington D.C.-USA (1980-1988, first at NIMH/St. Elizabeth’s Hospital and later at Georgetown University/FGIN) and Rome-Italy. Currently Dr. Barbaccia is full professor of Pharmacology at the University of Rome Tor Vergata Medical School. She has authored/co-authored more than 90 scientific publications, mostly on peer-reviewed international journals. Orcid Scopus RsearcherId
cn_ebm_andris_001 Baskys Andrius Graduate College of Biomedical Sciences Western University of Health Sciences Pomona, CA USA

Dr. Baskys has obtained a Ph. D degree and he is a Psychiatrist at University of California Riverside School of Medicine USA. His area of interest includes Neurobiology, Neurodegenerative diseases, Clinical Psychiatry, Neurodegeneration, Neurophysiology, Neurobiology and Brain. Scopus RsearcherId
cn_ebm_f-baudry_001 Baudry Michel Graduate College of Biomedical Sciences University of Southern California Los Angeles, CA USA

Dr. Baudry is the Dean and graduate College of Biomedical Sciences at Western University of Health Sciences; he is former professor of biological sciences, neurology and biomedical engineering at the University of Southern California. He is an internationally known neuroscientist who has published more than 400 manuscripts in peer-reviewed journals. Besides he is one of the 100 most-cited neuroscientists in the world, according to the ISI database and served on numerous National Science Foundation and National Institutes of Health studies. He graduated from Ecole Polytechnique, Paris in 1971 and earned PhD in biochemistry from the University of Paris VII in 1977 under the direction of professors J.C. Schwartz and J.P. Changeux, who are two of France’s most distinguished neurobiologists. Scopus RsearcherId
cn_ebm_f-stephen_001 Benoit Stephen C. Department of Psychiatry University of Cincinnati Cincinnati, OH USA

Dr. Benoit obtained a Ph.D. degree and he is an associate professor of Psychiatry and Behavioral Neuroscience, Director of Continuing Medical Education, Benoit. His research interests focus on neurobiological controls over behavior with emphasis on food intake and learning. Other studies have focused on the role of learning in the control of ingestive behavior Research Areas Obesity, Learning, Neuroendocrinology.

cn_ebm_p-bhide_001 Bhide Pradeep G. Department of Biomedical Sciences Florida State University College of Medicine Tallahassee, FL USA

Dr. Bhide is Eminent Scholar, Professor and Director of the Center for Brain Repair at Florida State University College of Medicine. He received his degree in Veterinary Medicine from Veterinary College, Bangalore, India, and a PhD in Neuroscience from the University of Aberdeen, Scotland. He obtained postdoctoral research training at University College London, England, Yale University, New Haven, CT, Massachusetts General Hospital, Boston, MA and Harvard Medical School, Boston, MA. Dr. Bhide was Associate Professor of Neurology at Harvard Medical School and Vice Chair for Neurology Research at Massachusetts General Hospital, in Boston until 2011, when he accepted his current position at FSU. Dr. Bhide is senior editor of the journal Developmental Neuroscience. He has served on various committees for a number of scientific organizations including the US National Institutes of Health, Veterans Administration, Autism Speaks and National Parkinson’s Foundation. Dr. Bhide founded Avekshan LLC, a Tallahassee based pharmaceutical company in 2013. Orcid Scopus RsearcherId
cn_ebm_blokland_001 Blokland Arjan Department of Neuropsychology and Psychopharmacology Maastricht University Maastricht The Netherlands

Dr. Arjan Blokland received his PhD in Neuroscience from Maastricht University in 1992. He did a post doc at the University of Cambridge in 1992. In 1993 he took a position as laboratory head at Tropon (CNS research Bayer. He returned to Maastricht University in 1996 as a Research Fellow. Currently, he is an associate Professor and Head of Department of Neuropsychology & Psychopharmacology at the Faculty of Psychology and Neuroscience. He published over 170 papers in international peer reviewed journals, and is a co-inventor of 4 patents (pending). He received various types of funding for his research and has many collaborations in Maastricht and the rest of the world. Orcid Scopus RsearcherId
cn_ebm_boehm_001 Boehm Stefan Department of Neurophysiology and Pharmacology Medical University of Vienna Vienna Austria

Dr. Boehm obtained an MD from the University of Vienna, Austria, in 1987 and received his postdoctoral education in Vienna and Frankfurt/Main, Germany. He had been Professor of Neuropharmacology at the Medical University of Graz and was appointed Professor of Neuropharmacology at the Medical University of Vienna in 2007. There, he is head of the Department of Neurophysiology and Neuropharmacology at the Center for Physiology and Pharmacology and Director of the Doctoral School. His research focuses on mechanisms underlying pre‐ as well as postsynaptic modulation of synaptic transmission and on mechanisms of action of analgesic as well as anticonvulsant drugs. RsearcherId
cn_ebm_boison_001 Boison Detlev Robert Wood Johnson Medical School Rutgers University Piscataway, NJ USA

Detlev Boison, PhD, is the Vice Chair of Research and Training and Professor, RWJMS & NJMS Neurosurgery Department Rutgers, The State University of New Jersey School of Public Health Bldg. Dr. Boison has a passion for translational research and for finding cures for intractable conditions that cause human suffrage and death. He translates fundamental mechanisms of biochemistry and energy metabolism into novel therapeutic approaches for the treatment of neurological conditions. A major research effort is the development of metabolism-based therapies that enable disease modification in epilepsy and after traumatic brain injury. He graduated from the University of Köln, Germany, in 1994 with a PhD in Biochemistry. In 2005, he received the venia legend (Habilitation) in Cellular Pharmacology from the University of Zurich, Switzerland, for his work on cell-based adenosine augmentation therapies for epilepsy. Over the past 25 years he maintained a rigorous research program on translational adenosine research and has continuously funded NIH since 2008. His research interest is in Neurology, The adenosine hypothesis of schizophrenia, Role of adenosine in cancer and Metabolic therapies etc. He has published over 190 papers with an h-index of 62 and has delivered over 150 invited lectures worldwide. Scopus RsearcherId
cn_ebm_bokkon_001 Bokkon Istvan Vision Research Institute Budapest Hungary

István Bókkon is a research fellow at Psychoszomatic Outpatient Department, Budapest, Hungary and a Professor at Vision Research Institute, Neuroscience Department, Lowell, MA, USA. He is also a lecturer at Károli Gáspár University of the Reformed Church, Psychology Department in Hungary. He graduated as a chemical engineer and later as a bioengineer at the Technical University Budapest. Then, he performed PhD studies and got pre-degree certificate at the Semmelweis University in Pharmacology. He has a research focus on biophysical neuroscience. His main areas of research interest are functional role of free radicals, unconscious processes, visual thinking, visual representations and epigenetics. He has published over 35 peer reviewed papers, some invited reviews and book chapters. His papers have been cited over 400 times. Scopus RsearcherId
cn_ebm_bolshakov_001 Bolshakov Vadim Department of Psychiatry Harvard Medical School Belmont, MA USA

Dr. Bolshakov performed his post-doctoral studies at Columbia University in New York under the mentorship of Dr. Steven Siegelbaum. He joined McLean Hospital/Harvard Medical School in 1999, and he is presently a professor at HMS. In his studies, Dr. Bolshakov focuses on understanding cellular and molecular mechanisms of learned and innate behaviors using a combination of electrophysiological, cell biological, and optogenetic techniques. Scopus RsearcherId
Bonuccelli Ubaldo Dipartimento di Neuroscienze Universita di Pisa Rome Italy Orcid Scopus RsearcherId cn_ebm_brandt_001 Brandt Roland Department of Neurobiology Universitaet Osnabrck Osnabrück Germany

Roland Brandt studied biochemistry and philosophy at the Universities of Tübingen and Berlin. After obtaining his doctoral degree at the Free University of Berlin, he continued as postdoctoral researcher at the Center for Neurologic Diseases (CND) at Harvard Medical School, Boston (USA). After returning to Germany, he became an independent research group leader at the Interdisciplinary Center for Neuroscience (IZN) of the University of Heidelberg. Since 2002 he is Full Professor and Head of the Department of Neurobiology at the University of Osnabrück. He has published more than 80 scientific publications, co-edited two books and is currently editorial board member of “Current Neuropharmacology”, review editor of “Frontiers in Neurodegeneration”, associate editor of “Biological Chemistry”, and honorary editorial board member of “Brain Research Bulletin”. Orcid Scopus RsearcherId
cn_ebm_bruijnzeel_001 Bruijnzeel Adriaan W. Department of Psychiatry University of Florida Gainesville, FL USA

Dr. Bruijnzeel obtained a Ph.D. degree in Neuropsychopharmacology, from Utrecht University. He is an Associate Professor at University of Florida College of Medicine, USA. His current research focuses on drug addiction, stress, anxiety, nicotine, alcohol, and opioid addiction. His research areas are Nicotine and alcohol dependence of brain.

awbruijn@UFL.EDU Orcid Scopus RsearcherId
cn_ebm_cadet_001 Cannella Milena Department of Neuropharmacology Neuromed Mediterranean Neurological Institute Pozzilli Italy

Ph.D. Milena Cannella is a researcher both in the Department of Neuropharmacology at IRCCS Neuromed since 2007 and in the Department of Molecular Genetics at the same institution since 2019. She received her PhD from University of Catania in 2004, and developed postdoctoral work at the UMDNJ in Newark (USA). She received the national qualification as Associate Professor in 2018. She has published articles on genetic diseases, mice lacking metabotropic glutamate receptors for the study on CNS disorders. Her current research work broadly focuses on neurogenetics, quantitative genetics and neurobiology of psychiatry disorders such as schizophrenia and other neurodevelopmental disorders. Orcid Scopus RsearcherId
cn_ebm_cadet_001 Cadet Jean L. Molecular Neuropsychiatry Research Branch DHHS/NIH/NIDA Intramural Research Program Univ. College of Physicians and Surgeons Baltimore, MD USA

Dr. Cadet has obtained his Ph. D and he is a researcher and focuses on studies of the molecular and cellular mechanisms of psychostimulant addiction and toxicity. Dr. Cadet’s group has provided recent evidence that methamphetamine (METH) self-administration is accompanied with markers of toxicity in striatal dopaminergic systems. These results are consistent with the idea that catecholamines, especially, dopamine can activate neurodegenerative processes in the mammalian brain. Research Areas: Neuropeptides, Dopaminergic Systems, Neurodegnerative processes, Brain. Orcid Scopus RsearcherId
cn_ebm_pp-calabresi_001 Calabresi Paolo Department of Medicine, Hospital Santa Maria della Misericordia, Neurological Clinic University of Perugia Perugia Italy

Dr. Calabresi has obtained his Ph.D and he is a full professor at Neurology and Chairman of Neurology at the University of Perugia, Italy. In the last two decades, Prof. Calabresi’s research has investigated the synaptic communication between the cerebral cortex and the basal ganglia, focussing on corticostriatal synapses and their activity-dependent plasticity. In particular, Prof. Calabresi’s group has extensively investigated how corticostriatal communication depends on the activation of dopamine receptors and how it is affected by pathological conditions such as Parkinson’s disease. Research Areas: Dopamine-mediated regulation, neurons, Parkinson's disease, basal ganglia. Orcid Scopus RsearcherId
cn_ebm_calkins_001 Calkins David J. Department of Ophthalmology and Visual Sciences Vanderbilt University Medical Center Nashville, TN USA

Dr. Calkins holds a doctorate (Ph.D.) in Neuroscience from the University of Pennsylvania, Philadelpha. He is currently Professor of Ophthalmology & Visual Sciences and Pharmacology in the Vanderbilt University School of Medicine and Director of the Vanderbilt Vision Research Center. He also is Vice Chair and Director for Research of the Vanderbilt Eye Institute. He has published more over 70 primary research articles, reviews and chapters and serves on the editorial board for several journals. Orcid Scopus RsearcherId
cn_ebm_costa_001 Cristine Alves Da Costa Institute de Pharmacologie Moleculaire et Cellulaire Université Côte d'Azur Valbonne France

Dr. Cristine Alves da Costa obtained a doctorate (PhD) in Toxicology from the Faculty of Pharmaceutical Sciences, University of São Paulo, USP, Brazil in 1997. Actually, Dr .Alves da Costa is a research director at INSERM and drives a team at the “Institute of Pharmacology Moléculaire et Cellulaire” (IPMC-CNRS). Her research interests include neurodegenerative diseases and brain tumors. Dr. Alves da Costa is currently an Editorial board member of this journal (Current Neuropharmacology), published by Bentham Science Publishers. Orcid Scopus RsearcherId
cn_ebm_cucullo_001 Cucullo Luca Dept. of Foundational Medical Studies Oakland University William Beaumont School of Medicine Rochester, MI USA

Dr.Luca Cucullo is a Professor in the Dept of Foundational Medical Studies at Oakland University William Beaumont School of Medicine.He has over 20 years of research experience in cerebrovascular modeling in vitro for toxicological, pharmacokinetic and pharmacodynamic studies of drugs targeting the brain. Dr. Cucullo's research interests are largely focused the cross interactions between the cellular elements of the neurovascular unit, the development of multidrug resistance at the BBB, biomarkers of BBB disruption, environmental and cellular modulation of BBB functions and their relevance to the onset of neuroinflammation, stroke/ischemia, and the pathogenesis of secondary brain injury. Orcid Scopus RsearcherId
cn_ebm_fallarino-f_001 Fallarino Francesca Department of Experimental Medicine University of Perugia Perugia Italy

Francesca Fallarino is an associate professor at the University of Perugia (Italy), department of experimental Medicine. Francesca Fallarino’s reseach focus is on the study of the specific mechanisms involved in immune regulation. In this field, she has greatly contributed to the subject of immune tolerance, providing evidence that: (a) tryptophan catabolism in tolerogenic dendritic cells can exert profound immunoregulatory effects on T lymphocytes as well as on otherwise immunostimulatory dendritic cells (DCs); (b) kynurenines, the products of tryptophan catabolism, can regulate neuroinflammation and in autoimmunity through the activation of specific receptors. Orcid RsearcherId
cn_ebm_felder_001 Felder Christian C. Neuroscience Division Lilly Corporate Center Indianapolis, IN USA

Dr. Christian Felder received a BS in Chemistry from the College of William and Mary, and his PhD in Biochemistry from Georgetown University School of Medicine. He is currently a Research Fellow in the Neuroscience Division at Eli Lilly & Co. in Indianapolis where he leads a drug development research lab focused on neurological and neuropsychiatric diseases. He is also the program Director for the external Lilly Innovation Fellowship Awards program (LIFA) and internal Lilly Research Labs post doc program. Dr. Felder has published over 130 scientific articles, reviews and book chapters and has had numerous invitations to speak at universities and international scientific conferences.

cn_ebm_Sari-Goldstein_001 Ferber Sari Goldstein Department of Psychology and Gonda Brain Research Center Bar Ilan University Ramat Gan Israel

Sari Goldstein Ferber, PhD, is a clinical psychologist trained at the Department of Psychiatry, Harvard University Medical School. In her PhD dissertation, she pioneered innovative neurobehavioral treatments in Neonatal Intensive Care Units in Israel. She is an associate of the highly ranked journal Behavioral and Brain Sciences, with publications in this journal and on The Editorial Board of other High ranked Journals in Psychiatry and Neuroscience. She received the Fulbright New Century Scholar award and is a USA Department of State Alumna. She received many grants, including a US-Israel Bi-National Research Foundation grant. She was a Visiting Professor at Columbia University. She published around 40 scientific articles in highly ranked journals. Her recent publications focus on biological clocks and control systems models.

Scopus RsearcherId
cn_ebm_fiore-m_001 Fiore Marco Department of Sense Organs Institute of Biochemistry and Cell Biology, IBBC-CNR Rome Italy

Marco Fiore is a researcher at the Institute of Biochemistry and Cell Biology of the Italian National Research Council IBBC-CNR. He graduated in Natural Sciences and Biological Sciences at the Sapienza University of Rome, Italy. He received his Ph.D. in Medical Sciences at the Psychiatric Department of the University of Groningen, the Netherlands. Also, he potentiated his professional experience at the Institute of Zoology, Oxford University, UK and at the Department of Physiology and Behavior, University of California at Davis, CA-USA. Orcid Scopus RsearcherId
cn_ebm_illes_001 Illes Peter Rudolf-Boehm-Institute of Pharmacology and Toxicology University of Leipzig Leipzig Germany

Peter Illes has studied medicine and has been Associate Professor in the Department of Pharmacology of the University of Freiburg and afterwards Full Professor and Director of the Department of Pharmacology of the University of Leipzig, Germany He has obtained numerous awards and distinctions; he is also member of several professional organizations such as the Academia Europaea or the Czech Learned Society. He has been awarded by a honorary Doctorate in Budapest, Hungary, and honorary Professorates in Shanghai and Chengdu, China. He is neuroscientist with special emphasis on two types of ATP-sensitive receptors, belonging to the P2X3 and P2X7 class. Scopus RsearcherId
cn_ebm_iwata_001 Iwata Nobuhisa Department of Genome-based Drug Discovery Graduate School of Biomedical Sciences Nagasaki University Nagasaki Japan

Dr. Nobuhisa Iwata obtained a Ph.D. in Pharmacology from Tokyo University of Pharmacy and Life Sciences (Tokyo, Japan), then worked at National Institute of Health Sciences (Tokyo, Japan), Tokyo Medical University (Tokyo, Japan), National Heart, Lung, and Blood Institute (Bethesda, US), and RIEKN Brain Science Institute (Wako, Japan). Currently Dr. Iwata is a full professor in Graduate School of Biomedical Sciences, Nagasaki University. He has published more than 100 scientific publications, including Science, Nature Medicine, Nature Neuroscience, Neuron, Cell Stem Cell, etc. Dr. Iwata was appointed the Regional Editor of this journal (Current Neuropharmacology, CN), published by Bentham Science Publishers, in 2004. Orcid Scopus RsearcherId
cn_ebm_kalinichev_001 Kalinichev Mikhail H. Lundbeck A/S Copenhagen Denmark

Dr. Mikhail Kalinichev obtained a doctorate (Ph.D.) in Behavioral Neuroscience from the Center for Molecular & Behavioral Neuroscience, Rutgers University (USA). Currently Dr. Kalinichev is a Director, In Vivo Neurology-Toxins in Ipsen Innovation, France. Previously, Dr. Kalinichev worked at Lundbeck pharmaceuticals (Denmark), Addex Therapeutics (Switzerland) and GlaxoSmithKline (UK). He has published more than 40 scientific publications. Scopus RsearcherId
cn_ebm_Thomas-Kuhn-ab_001 Kuhn Thomas Department of Biochemistry and Molecular Biology Colorado State University Fort Collins, CO USA

Tom Kuhn is an Adjunct Professor at Colorado State University (Biochemistry and Molecular Biology) and Professor Emeritus at the University of Alaska Fairbanks (Biochemistry and Neuroscience). His research is focused on the molecular mechanisms of inflammatory and oxidative stress in the context of CNS neurodegeneration and AIDS dementia. He founded Cereon Biotechnology LLC utilizing a natural products-based drug discovery approach to blunt CNS neurodegeneration. He directed the graduate program in Biochemistry and Neuroscience at UAF for 12 years and established the annual AK state-wide One Health Research Conference (ORCA).

Scopus RsearcherId
cn_ebm_Maciejczyk-ma_001 Maciejczyk Mateusz Department of Hygiene, Epidemiology and Ergonomics Medical University of Bialystok Białystok Poland

Dr. Mateusz Maciejczyk is an Assistant Professor in the Department of Hygiene, Epidemiology, and Ergonomics (Medical University of Bialystok, MUB, Poland). Dr. Mateusz Maciejczyk’s scientific output includes about 100 publications in peer-reviewed scientific journals, comprising 68 original articles, 21 review papers, and 11 monographs, with a total impact factor of 347,46. According to the Web of Science, his h-index is 23. Dr. Mateusz Maciejczyk is also the author of 132 scientific meeting communiques and co-author of a patent application. Orcid Scopus RsearcherId
cn_ebm_nabavi-sm_001 Seyed Mohammad Nabavi Applied Biotechnology Research Center Baqiyatallah University of Medical Sciences Tehran Iran

Seyed Mohammad Nabavi is a biotechnologist and senior scientist of Applied Biotechnology Research Center, Baqiyatallah University of Medical Science and a member of Iran's National Elites Foundation. His research focuses on the molecular pharmacology of natural products. He is author/co-author of 250 publications in international journals, 51 communications at national and international congress, and six chapters in book series. Seyed Mohammad Nabavi has been selected as a group of scientists recognized as Highly Cited Researchers by Clarivate Analytics, 2018. Orcid Scopus RsearcherId
cn_ebm_nathan_001 Nathan Pradeep J. Department of Physiology Monash Alfred Psychiatry Research Centre Monash University Melbourne Australia

Prof. Pradeep Nathan is Vice President, CNS Clinical Development and Experimental Medicine at Heptares Therapeutics, and Professor of Neuroscience at Monash University. He read pharmacology and neuroscience at the University of Melbourne followed by a PhD in Neuroscience. He has more than 20 years clinical research experience and held positions in both academia and industry. Prof. Nathan has published more than 200 research papers and his research has been cited over 8500 times in academic journals. He has received many research awards including the Australian Young Tall Poppy Science Award, the Brain and Behaviour Foundation, Independent Investigator Award and the British Association for Psychopharmacology, Clinical Psychopharmacology Award. Scopus RsearcherId
cn_ebm_popoli_001 Popoli Maurizio Department of Pharmacological Sciences University of Milano Milano Italy

MP is Professor of Pharmacology at University of Milano (Italy). He was trained in Biochemistry/Cell Biology at University of Naples and received postdoctoral training at Int. Inst. Genet. Biophysics (Naples), and Dept. of Psychiatry at Washington University, (St. Louis, MO). His studies have contributed to characterization of cellular/molecular mechanisms involved in pathophysiology of neuropsychiatric disorders and psychotropic drug action. He received a NARSAD Independent Investigator Award, and funding from national and international agencies, including EU. He is author of 120 publications, and currently field editor or editorial board member of neuropsychopharmacology/biological psychiatry journals. Orcid Scopus RsearcherId
cn_ebm_rajadas_001 Rajadas Jayakumar Biomaterials & Advanced Drug Delivery Laboratory (BioADD) Stanford University Stanford, CA USA

Dr. Jayakumar Rajadas is currently working on the molecular mechanism of protein-initiated neurodegenerative disorders involved in Alzheimer’s and Lyme disease development using biophysical approaches. He is the founding director of the Biomaterials and Advanced Drug Delivery Laboratory at Stanford School of Medicine. Dr. Rajadas obtained a doctorate in Chemistry from Indian Institute of technology. He has 72 US patents and pending applications. He has also authored 188 papers. Scopus RsearcherId
cn_ebm_Rogawski-ma_001 Rogawski Michael A. Department of Neurology University of California Sacramento, CA USA

Dr. Michael Rogawski is a professor of Neurology and Pharmacology at the University of California, Davis. Until 2006, he was senior investigator and chief of the Epilepsy Research Section at the National Institute of Neurological Disorders and Stroke. Dr. Rogawski holds a B.A. in biophysics from Amherst College and an M.D. and Ph.D. in pharmacology. Dr. Rogawski’s research encompasses cellular neurophysiological studies of ion channels; animal models of neurological disease, including epilepsy; and clinical studies of new therapeutics. His laboratory studies on AMPA receptors and neurosteroids have led to new treatment approaches for seizures and epilepsy, and the marketed treatment for postpartum depression brexanolone.

Orcid Scopus RsearcherId
cn_ebm_sharma-b_001 Sharma Bechan Department of Biochemistry University of Allahabad Allahabad India

Dr. Bechan Sharma is presently working as a Professor, Biochemistry Department, Allahabad University, India. His interest includes Molecular Biology, Tropical Diseases and Biochemical Toxicology. With 30 years of teaching / research experience, he has received number of Awards and Honors. He has published over 170 research papers, 4 books and one US patent. He has supervised 15 PhDs and 5 PDFs. He is a Editorial Board /Reviewer member for 130 International journals. He has widely visited to USA and other European labs. He is currently involved in a multinational research project with Koyoto University-Japan on anti HIV-1Drug design and development. Orcid Scopus RsearcherId
cn_ebm_suk_001 Suk Kyoungho Department of Pharmacology Kyungpook National University Daegu Republic of Korea

Dr. Kyoungho Suk is a member of editorial board for the journal. He is currently a professor of Department of Pharmacology, Kyungpook National University (KNU) School of Medicine (Daegu, Korea), and the director of Brain Science & Engineering Institute of KNU. He obtained his Ph.D. in Immunology at University of California at Davis in 1994, and M.S. degree in Immunology at Cornell University in 1991. He graduated from KNU with the genetic engineering major in 1989. Dr. Suk received his postdoctoral training in the division of Rheumatology, Yale University School of Medicine, and he has been a visiting professor at Harvard Medical School between 2008 and 2009, during which he participated in large-scale experiments and systems biology approaches toward understanding of disease networks and pathways. Dr. Suk is the author of more than 200 papers published in peer-reviewed journals and holds patents on various therapeutic targets and lead compounds that could be used for the diagnosis or therapy of neuroinflammatory and neurodegenerative diseases. Orcid Scopus RsearcherId
cn_ebm_Qun-Zhou_001 Zhou Ya-Qun Department of Anesthesiology and Pain Medicine Tongji Medical College Huazhong University of Science and Technology Wuhan China

Dr. Zhou received his Ph.D. degree from Huazhong University of Science and Technology, China in 2019. He is now an attending physician in the Department of Anesthesiology and Pain Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. His field of interest is chronic pain. He is the principal investigator of a research program funded by the National Natural Science Foundation of China. He is the author of over 40 peer-reviewed publications. Orcid Scopus RsearcherId
Associate Editorial Board Member cn_ebm_bagdas-d_001 Bagdas Deniz Department of Psychiatry Yale University School of Medicine New Haven, CT USA

Deniz Bagdas is an Associate Research Scientist in the Department of Psychiatry at Yale University School of Medicine, the USA, and an Associate Professor of Medical Pharmacology at Uludag University, Turkey. After she received her DVM, she earned her Ph.D. in Pharmacology and Toxicology. During her Ph.D. and post-doctoral career, she had extensive training in behavioral neuroscience. Her interests are focused on the role of neuronal nicotinic acetylcholine receptors in addiction as well as pain and inflammation. Currently, she has been investigating the impact of flavors on nicotine use with a focus on behaviors related to nicotine addiction in both adults and adolescence. Scopus RsearcherId
Executive Guest Editors cn_ebm_Ahmadi_001 Ahmadi Amirhossein Faculty of Pharmacy Mazandaran University of Medical Sciences Sari Iran

Amirhossein Ahmadi is an experienced researcher with a demonstrated history of research in the field of pharmaceutical sciences. He is skilled in clinical research, animal models, cellular models, scientific writing & publishing. He has focused on extensive fields of Pharmacology & Toxicology, Natural products, Radiopharmaceuticals, Nanomedicine, Radiation biology, Cancer chemoradiotherapy and other fields of Pharmacy at the Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. He has published many reviews in high-quality journals and was selected as a recognized international editor and peer reviewer by famous publishers. In 2019, he was placed among the top 1% of the reviewers in Cross-Field on Publons global reviewer database. Orcid
© 2024 Bentham Science Publishers | Privacy Policy